ArticleOpen life sciences2022

Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine.

Zhegang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.